April 22, 2026 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis
April 22, 2026 Press Release: Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
